Scope - The scope of this report includes: - Annualized market data for the gastrointestinal disorder therapeutics market from 2001 to 2009, forecast forward to 2016 - Analysis of the leading therapeutic segments. These include crohn's disease, ulcerative colitis, irritable bowel syndrome, and gastroesophageal reflux disease. - Analysis of the gastrointestinal disorder therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan - Market characterization of the gastrointestinal disorder therapeutics market including market size, annual cost of therapy, and treatment usage patterns - Key drivers and barriers that have a significant impact on the market - Coverage of pipeline molecules in various phases of drug development - Competitive benchmarking of leading companies. The key companies studied in this report are AstraZen
Copyright©2010 PR Newswire.
All rights reserved